Skip to main content
COGNITION THERAPEUTICS INC logo

COGNITION THERAPEUTICS INC — Investor Relations & Filings

Ticker · CGTX ISIN · US19243B1026 US Professional, scientific and technical activities
Filings indexed 281 across all filing types
Latest filing 2022-06-13 Director's Dealing
Country US United States of America
Listing US CGTX

About COGNITION THERAPEUTICS INC

https://cogrx.com/

Cognition Therapeutics, Inc. is a clinical-stage neuroscience company that discovers and develops oral, small-molecule therapeutics for neurodegenerative disorders. The company's primary focus is on conditions such as Alzheimer's disease and Dementia with Lewy Bodies (DLB). Its therapeutic approach is centered on developing medications designed to target and modulate key cellular damage response mechanisms. By aiming to rescue trafficking deficits and restore normal cellular housekeeping functions, the company seeks to protect neurons, improve synaptic health, and ultimately address the cognitive decline associated with these diseases.

Recent filings

Filing Released Lang Actions
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-06-13 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 11, 2022, by Cognition Therapeutics, Inc. It announces the issuance of a press release regarding financial results for the quarter ended March 31, 2022. The text explicitly states that the press release is furnished as an exhibit and that the information is being furnished, not filed, and is not incorporated by reference. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length of the document is 3892 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE and the nature of the content, this document is best classified as a Regulatory Filing (RNS) because it is a current report announcing the release of financial results but does not contain the full financial report itself.
2022-05-11 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or definitive additional materials related to a shareholder meeting. It includes information about voting on proposals such as election of directors and ratification of auditors. It is not the actual proxy statement itself but additional materials related to the proxy solicitation process. The document is under 5,000 characters and primarily serves to inform shareholders about voting and proxy materials availability. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI).
2022-04-25 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-25 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans. It includes details about the registration of additional shares under the company's 2021 Equity Incentive Plan. The document references incorporation by reference of the company's Annual Report on Form 10-K but is itself a registration statement for equity securities, not a financial report or earnings release. It is a regulatory filing related to securities registration and not any of the other specific report types like Annual Report, Earnings Release, or Management Reports. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a certification but a full registration statement filing.
2022-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.